Brooks Laboratories [BROOKS] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Brooks Laboratories Ltd.

NSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Brooks Laboratories Ltd. wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Brooks Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Brooks Laboratories Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 8.34 73.73 Brooks Laboratories Ltd.
Price-to-Book Ratio 1.56 13.36 Brooks Laboratories Ltd.
Debt-to-Equity Ratio 6.77 27.04 Brooks Laboratories Ltd.
PEG Ratio -0.04 -17.55 Brooks Laboratories Ltd.
EV/EBITDA 25.01 52.76 Brooks Laboratories Ltd.
Profit Margin (TTM) 24.32% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 2.05% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 2.05% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity -10.16% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) -8.06% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $15.98M $-251.22M Brooks Laboratories Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -54.45% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 2.03 22.23 Brooks Laboratories Ltd.
Enterprise Value $1.95B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 2.20 22.65 Brooks Laboratories Ltd.
Gross Profit Margin (TTM) 45.68% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $30 $15 Brooks Laboratories Ltd.
Earnings per Share (Diluted) $7.35 $4.40 Brooks Laboratories Ltd.
Beta (Stock Volatility) 0.81 -0.17 Gujarat Themis Biosyn Ltd.

Brooks Laboratories Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

BROOKS
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Brooks Laboratories Ltd.-3.95%3.55%18.08%4.21%-34.87%-17.04%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Brooks Laboratories Ltd.-54.45%6.49%-35.78%-3.14%87.61%87.61%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Brooks Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBROOKSGUJTHEM
Market Information
Market Cap i₹1.90B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i124,10179,452
90 Day Avg. Volume i195,493106,446
Last Close₹64.40₹401.80
52 Week Range₹36.30 - ₹164.02₹225.05 - ₹479.00
% from 52W High-60.74%-16.12%
All-Time High₹198.86 (Jan 06, 2025)₹479.00 (Oct 27, 2025)
% from All-Time High-67.62%-16.12%
Growth Metrics
Quarterly Revenue Growth-0.57%0.10%
Quarterly Earnings Growth-0.57%-0.04%
Financial Health
Profit Margin (TTM) i0.24%0.30%
Operating Margin (TTM) i0.02%0.40%
Return on Equity (TTM) i-0.10%0.20%
Debt to Equity (MRQ) i6.7727.04
Cash & Liquidity
Book Value per Share (MRQ)₹39.30₹24.29
Cash per Share (MRQ)₹0.36₹0.92
Operating Cash Flow (TTM) i₹-42,666,000₹970.68M
Levered Free Cash Flow (TTM) i₹-99,670,000₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Brooks Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBROOKS (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i8.3473.73
Forward P/E i10.55N/A
PEG Ratio i-0.04-17.55
Price to Sales (TTM) i2.0322.23
Price to Book (MRQ) i1.5613.36
Market Capitalization
Market Capitalization i₹1.90B₹35.41B
Enterprise Value i₹1.95B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i2.2022.65
Enterprise to EBITDA i25.0152.76
Risk & Other Metrics
Beta i0.81-0.17
Book Value per Share (MRQ) i₹39.30₹24.29

Financial Statements Comparison: Brooks Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBROOKS (2025)GUJTHEM (2025)
Revenue/Sales i821.86M1.51B
Cost of Goods Sold i593.60M318.78M
COGS % of Revenue i72.2%21.1%
Gross Profit i228.25M1.19B
Gross Margin i27.8%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i65.27M642.49M
Operating Margin i7.9%42.6%
EBITDA i-42.57M713.04M
EBITDA Margin i-5.2%47.3%
Pre-Tax Income i-97.92M655.38M
Pre-Tax Income % of Revenue i-11.9%43.5%
Income Tax i1.75M167.66M
Income Tax % of Revenue i0.2%11.1%
Net Income (Profit) i-99.67M487.72M
Profit Margin i-12.1%32.3%

Balance Sheet & Liquidity Metrics

MetricBROOKS (2025)GUJTHEM (2025)
Cash & Equivalents i434,000116.94M
Total Current Assets i338.77M519.73M
Total Current Assets % of Revenue i41.2%34.5%
Total Current Liabilities i228.44M205.60M
Total Current Liabilities % of Revenue i27.8%13.6%
Long-Term Debt i13.70M296.36M
Long-Term Debt % of Revenue i1.7%19.7%
Total Shareholders Equity i981.04M2.48B
Retained Earnings i-486.52M2.37B
Retained Earnings % of Revenue i-59.2%157.4%
Property, Plant & Equipment i3.45M411.30M

Cash Flow Statement Comparison

MetricBROOKS (2025)GUJTHEM (2025)
Operating Cash Flow i-42.67M970.68M
Operating Cash Flow % of Revenue i-5.2%64.4%
Capital Expenditures i-9.13M-1.16B
Free Cash Flow i15.98M-251.22M
FCF Margin i1.9%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBROOKSGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i29.46M108.97M
Float Shares i13.27M29.52M
% Held by Insiders i56.02%71.98%
% Held by Institutions i9.90%1.18%
% Held by Public i34.08%26.84%

Dividend Analysis & Yield Comparison: Brooks Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBROOKSGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025